ABSTRACT
Recent advances in sequencing technologies and analytics have dramatically improved our understanding of the gut microbiota. We now have a solid foundation for studying the microbiota and thus recent efforts have focused on identifying how perturbations to the microbiota composition and function affect disease risk. This chapter focuses on the relationship between the microbiota and cardiometabolic risk with an emphasis on how diet modulates these effects.
